Paraneoplastic Syndrome Treatment Market - Global Outlook and Forecast 2022-2028

March 2022 | 63 pages | ID: P24BA7498B47EN
Market Monitor Global

Abstracts

A paraneoplastic syndrome is a rare group of disorder that is triggered by an abnormal immune system response caused by the neoplasm. This syndrome mostly occurs when cancer-fighting antibodies mistakenly attack normal cells in the nervous system. The prevalence of this disorder can be typically seen in the middle-aged population to older population. This syndrome mostly occurs with patients suffering from lung, ovarian, or breast cancers.

This report contains market size and forecasts of Paraneoplastic Syndrome Treatment in Global, including the following market information:

Global Paraneoplastic Syndrome Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Paraneoplastic Syndrome Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Medication Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Paraneoplastic Syndrome Treatment include Siemens Healthineers, Koninklijke Philips, General Electric, Esaote, NeuroLogica, Masimo, York Instruments, Neusoft Medical Systems and Canon Medical Systems. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Paraneoplastic Syndrome Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Paraneoplastic Syndrome Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Paraneoplastic Syndrome Treatment Market Segment Percentages, by Type, 2021 (%)

• Medication
• Physical Therapy
• Speech Therapy
• Others

Global Paraneoplastic Syndrome Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Paraneoplastic Syndrome Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Others

Global Paraneoplastic Syndrome Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Paraneoplastic Syndrome Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Paraneoplastic Syndrome Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Paraneoplastic Syndrome Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Siemens Healthineers
• Koninklijke Philips
• General Electric
• Esaote
• NeuroLogica
• Masimo
• York Instruments
• Neusoft Medical Systems
• Canon Medical Systems

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Paraneoplastic Syndrome Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Paraneoplastic Syndrome Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PARANEOPLASTIC SYNDROME TREATMENT OVERALL MARKET SIZE

2.1 Global Paraneoplastic Syndrome Treatment Market Size: 2021 VS 2028
2.2 Global Paraneoplastic Syndrome Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Paraneoplastic Syndrome Treatment Players in Global Market
3.2 Top Global Paraneoplastic Syndrome Treatment Companies Ranked by Revenue
3.3 Global Paraneoplastic Syndrome Treatment Revenue by Companies
3.4 Top 3 and Top 5 Paraneoplastic Syndrome Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Paraneoplastic Syndrome Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Paraneoplastic Syndrome Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Paraneoplastic Syndrome Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Paraneoplastic Syndrome Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Paraneoplastic Syndrome Treatment Market Size Markets, 2021 & 2028
  4.1.2 Medication
  4.1.3 Physical Therapy
  4.1.4 Speech Therapy
  4.1.5 Others
4.2 By Type - Global Paraneoplastic Syndrome Treatment Revenue & Forecasts
  4.2.1 By Type - Global Paraneoplastic Syndrome Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Paraneoplastic Syndrome Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Paraneoplastic Syndrome Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Paraneoplastic Syndrome Treatment Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Ambulatory Surgical Centers
  5.1.5 Others
5.2 By Application - Global Paraneoplastic Syndrome Treatment Revenue & Forecasts
  5.2.1 By Application - Global Paraneoplastic Syndrome Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Paraneoplastic Syndrome Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Paraneoplastic Syndrome Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Paraneoplastic Syndrome Treatment Market Size, 2021 & 2028
6.2 By Region - Global Paraneoplastic Syndrome Treatment Revenue & Forecasts
  6.2.1 By Region - Global Paraneoplastic Syndrome Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Paraneoplastic Syndrome Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Paraneoplastic Syndrome Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Paraneoplastic Syndrome Treatment Revenue, 2017-2028
  6.3.2 US Paraneoplastic Syndrome Treatment Market Size, 2017-2028
  6.3.3 Canada Paraneoplastic Syndrome Treatment Market Size, 2017-2028
  6.3.4 Mexico Paraneoplastic Syndrome Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Paraneoplastic Syndrome Treatment Revenue, 2017-2028
  6.4.2 Germany Paraneoplastic Syndrome Treatment Market Size, 2017-2028
  6.4.3 France Paraneoplastic Syndrome Treatment Market Size, 2017-2028
  6.4.4 U.K. Paraneoplastic Syndrome Treatment Market Size, 2017-2028
  6.4.5 Italy Paraneoplastic Syndrome Treatment Market Size, 2017-2028
  6.4.6 Russia Paraneoplastic Syndrome Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Paraneoplastic Syndrome Treatment Market Size, 2017-2028
  6.4.8 Benelux Paraneoplastic Syndrome Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Paraneoplastic Syndrome Treatment Revenue, 2017-2028
  6.5.2 China Paraneoplastic Syndrome Treatment Market Size, 2017-2028
  6.5.3 Japan Paraneoplastic Syndrome Treatment Market Size, 2017-2028
  6.5.4 South Korea Paraneoplastic Syndrome Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Paraneoplastic Syndrome Treatment Market Size, 2017-2028
  6.5.6 India Paraneoplastic Syndrome Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Paraneoplastic Syndrome Treatment Revenue, 2017-2028
  6.6.2 Brazil Paraneoplastic Syndrome Treatment Market Size, 2017-2028
  6.6.3 Argentina Paraneoplastic Syndrome Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Paraneoplastic Syndrome Treatment Revenue, 2017-2028
  6.7.2 Turkey Paraneoplastic Syndrome Treatment Market Size, 2017-2028
  6.7.3 Israel Paraneoplastic Syndrome Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Paraneoplastic Syndrome Treatment Market Size, 2017-2028
  6.7.5 UAE Paraneoplastic Syndrome Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Siemens Healthineers
  7.1.1 Siemens Healthineers Corporate Summary
  7.1.2 Siemens Healthineers Business Overview
  7.1.3 Siemens Healthineers Paraneoplastic Syndrome Treatment Major Product Offerings
  7.1.4 Siemens Healthineers Paraneoplastic Syndrome Treatment Revenue in Global Market (2017-2022)
  7.1.5 Siemens Healthineers Key News
7.2 Koninklijke Philips
  7.2.1 Koninklijke Philips Corporate Summary
  7.2.2 Koninklijke Philips Business Overview
  7.2.3 Koninklijke Philips Paraneoplastic Syndrome Treatment Major Product Offerings
  7.2.4 Koninklijke Philips Paraneoplastic Syndrome Treatment Revenue in Global Market (2017-2022)
  7.2.5 Koninklijke Philips Key News
7.3 General Electric
  7.3.1 General Electric Corporate Summary
  7.3.2 General Electric Business Overview
  7.3.3 General Electric Paraneoplastic Syndrome Treatment Major Product Offerings
  7.3.4 General Electric Paraneoplastic Syndrome Treatment Revenue in Global Market (2017-2022)
  7.3.5 General Electric Key News
7.4 Esaote
  7.4.1 Esaote Corporate Summary
  7.4.2 Esaote Business Overview
  7.4.3 Esaote Paraneoplastic Syndrome Treatment Major Product Offerings
  7.4.4 Esaote Paraneoplastic Syndrome Treatment Revenue in Global Market (2017-2022)
  7.4.5 Esaote Key News
7.5 NeuroLogica
  7.5.1 NeuroLogica Corporate Summary
  7.5.2 NeuroLogica Business Overview
  7.5.3 NeuroLogica Paraneoplastic Syndrome Treatment Major Product Offerings
  7.5.4 NeuroLogica Paraneoplastic Syndrome Treatment Revenue in Global Market (2017-2022)
  7.5.5 NeuroLogica Key News
7.6 Masimo
  7.6.1 Masimo Corporate Summary
  7.6.2 Masimo Business Overview
  7.6.3 Masimo Paraneoplastic Syndrome Treatment Major Product Offerings
  7.6.4 Masimo Paraneoplastic Syndrome Treatment Revenue in Global Market (2017-2022)
  7.6.5 Masimo Key News
7.7 York Instruments
  7.7.1 York Instruments Corporate Summary
  7.7.2 York Instruments Business Overview
  7.7.3 York Instruments Paraneoplastic Syndrome Treatment Major Product Offerings
  7.7.4 York Instruments Paraneoplastic Syndrome Treatment Revenue in Global Market (2017-2022)
  7.7.5 York Instruments Key News
7.8 Neusoft Medical Systems
  7.8.1 Neusoft Medical Systems Corporate Summary
  7.8.2 Neusoft Medical Systems Business Overview
  7.8.3 Neusoft Medical Systems Paraneoplastic Syndrome Treatment Major Product Offerings
  7.8.4 Neusoft Medical Systems Paraneoplastic Syndrome Treatment Revenue in Global Market (2017-2022)
  7.8.5 Neusoft Medical Systems Key News
7.9 Canon Medical Systems
  7.9.1 Canon Medical Systems Corporate Summary
  7.9.2 Canon Medical Systems Business Overview
  7.9.3 Canon Medical Systems Paraneoplastic Syndrome Treatment Major Product Offerings
  7.9.4 Canon Medical Systems Paraneoplastic Syndrome Treatment Revenue in Global Market (2017-2022)
  7.9.5 Canon Medical Systems Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Paraneoplastic Syndrome Treatment Market Opportunities & Trends in Global Market
Table 2. Paraneoplastic Syndrome Treatment Market Drivers in Global Market
Table 3. Paraneoplastic Syndrome Treatment Market Restraints in Global Market
Table 4. Key Players of Paraneoplastic Syndrome Treatment in Global Market
Table 5. Top Paraneoplastic Syndrome Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Paraneoplastic Syndrome Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Paraneoplastic Syndrome Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Paraneoplastic Syndrome Treatment Product Type
Table 9. List of Global Tier 1 Paraneoplastic Syndrome Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Paraneoplastic Syndrome Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Paraneoplastic Syndrome Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Paraneoplastic Syndrome Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Paraneoplastic Syndrome Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Paraneoplastic Syndrome Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Paraneoplastic Syndrome Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Paraneoplastic Syndrome Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Paraneoplastic Syndrome Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Paraneoplastic Syndrome Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Paraneoplastic Syndrome Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Paraneoplastic Syndrome Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Paraneoplastic Syndrome Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Paraneoplastic Syndrome Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Paraneoplastic Syndrome Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Paraneoplastic Syndrome Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Paraneoplastic Syndrome Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Paraneoplastic Syndrome Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Paraneoplastic Syndrome Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Paraneoplastic Syndrome Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Paraneoplastic Syndrome Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Siemens Healthineers Corporate Summary
Table 31. Siemens Healthineers Paraneoplastic Syndrome Treatment Product Offerings
Table 32. Siemens Healthineers Paraneoplastic Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Koninklijke Philips Corporate Summary
Table 34. Koninklijke Philips Paraneoplastic Syndrome Treatment Product Offerings
Table 35. Koninklijke Philips Paraneoplastic Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 36. General Electric Corporate Summary
Table 37. General Electric Paraneoplastic Syndrome Treatment Product Offerings
Table 38. General Electric Paraneoplastic Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Esaote Corporate Summary
Table 40. Esaote Paraneoplastic Syndrome Treatment Product Offerings
Table 41. Esaote Paraneoplastic Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 42. NeuroLogica Corporate Summary
Table 43. NeuroLogica Paraneoplastic Syndrome Treatment Product Offerings
Table 44. NeuroLogica Paraneoplastic Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Masimo Corporate Summary
Table 46. Masimo Paraneoplastic Syndrome Treatment Product Offerings
Table 47. Masimo Paraneoplastic Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 48. York Instruments Corporate Summary
Table 49. York Instruments Paraneoplastic Syndrome Treatment Product Offerings
Table 50. York Instruments Paraneoplastic Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Neusoft Medical Systems Corporate Summary
Table 52. Neusoft Medical Systems Paraneoplastic Syndrome Treatment Product Offerings
Table 53. Neusoft Medical Systems Paraneoplastic Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Canon Medical Systems Corporate Summary
Table 55. Canon Medical Systems Paraneoplastic Syndrome Treatment Product Offerings
Table 56. Canon Medical Systems Paraneoplastic Syndrome Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Paraneoplastic Syndrome Treatment Segment by Type in 2021
Figure 2. Paraneoplastic Syndrome Treatment Segment by Application in 2021
Figure 3. Global Paraneoplastic Syndrome Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Paraneoplastic Syndrome Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Paraneoplastic Syndrome Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Paraneoplastic Syndrome Treatment Revenue in 2021
Figure 8. By Type - Global Paraneoplastic Syndrome Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Paraneoplastic Syndrome Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Paraneoplastic Syndrome Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Paraneoplastic Syndrome Treatment Revenue Market Share, 2017-2028
Figure 12. US Paraneoplastic Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Paraneoplastic Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Paraneoplastic Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Paraneoplastic Syndrome Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Paraneoplastic Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Paraneoplastic Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Paraneoplastic Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Paraneoplastic Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Paraneoplastic Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Paraneoplastic Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Paraneoplastic Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Paraneoplastic Syndrome Treatment Revenue Market Share, 2017-2028
Figure 24. China Paraneoplastic Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Paraneoplastic Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Paraneoplastic Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Paraneoplastic Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Paraneoplastic Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Paraneoplastic Syndrome Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Paraneoplastic Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Paraneoplastic Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Paraneoplastic Syndrome Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Paraneoplastic Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Paraneoplastic Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Paraneoplastic Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Paraneoplastic Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Siemens Healthineers Paraneoplastic Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Koninklijke Philips Paraneoplastic Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. General Electric Paraneoplastic Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Esaote Paraneoplastic Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. NeuroLogica Paraneoplastic Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Masimo Paraneoplastic Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. York Instruments Paraneoplastic Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Neusoft Medical Systems Paraneoplastic Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Canon Medical Systems Paraneoplastic Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)